Injectable shaping agents include neurotoxins (botulinum toxin type A products), replacement fillers (hyaluronic acid [HA] agents), and biostimulatory fillers (calcium hydroxylapatite [CaHA], polymethylmethacrylate [PMMA], and poly-L-lactic acid [PLLA]). This article presents an overview of the agents currently available for use in facial rejuvenation in the United States.
|Original language||English (US)|
|Journal||Aesthetic surgery journal / the American Society for Aesthetic Plastic surgery|
|State||Published - Jan 1 2010|
ASJC Scopus subject areas